Funding for this research was provided by:
Text and Data Mining valid from 2020-02-03
Received: 5 August 2019
Accepted: 20 November 2019
First Online: 3 February 2020
Ethics approval and consent to participate
: The study was approved by the UCLA institutional review board (IRB#12–001547, IRB#14–001148). Written consent from study participants was obtained.
: Not applicable.
: EAC: none reported; GSK: none reported; JB: none reported; RDA serves as a consultant for Ferring, Flexion, GSK, Novartis, Olatec, and Pfizer; JF: none reported; ARFS: none reported; DAE: none reported; VKR has received research support and grants from Genentech (IST grant), Pfizer (IST grant), Mallinkrodt (IST grant), BMS (ad board), and Amgen (DSMB).